The request is part of President Trump’s budget and has taken on new urgency with the spread of the coronavirus worldwide.
The FDA does not have the same authorities for medical device shortages as it does for drugs and biological products, according to Hahn. Medtech manufacturers are under no legal obligation to notify the FDA of a potential shortage or to respond to agency requests about potential supply-chain disruption, he added.